2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3351
  



  

  
Submitter : 
  

  
Mr. Art Berman
  

  
Date & Time: 
  

  
12/15/2006 08:12:09
  



  

  
Organization : 
  

  
Mr. Art Berman
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 "I would like to appeal upon the nations vaccine makers to develop, as soon as possible, vaccines that are not cultivated on cells taken from aborted fetuses. The pharmaceutical companies that manufacture the vaccines made from aborted babies have the ability and know-how to produce versions of these vaccines which do not depend on cell lines from aborted children.  The pharmaceutical should be pressured by the FDA to develop those vaccines to meet the health needs of those who have religious and ethical objections to abortion.  The FDA has the authority to allow for the licensing and importation of safe and effective ethical alternative vaccines such as Takahashi (rubella) and Aimmugen (Hepatitis A), and it has a m oral duty to exercise that authority.  Pharmaceutical companies and the FDA have a responsibility to address these concerns and provide vaccines that can be used by all."